NASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis $5.07 +0.52 (+11.43%) As of 01/3/2025 05:39 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends About Nutriband Stock (NASDAQ:NTRB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nutriband alerts:Sign Up Key Stats Today's Range$4.55▼$5.1650-Day Range$3.85▼$6.3552-Week Range$2.22▼$9.60Volume55,961 shsAverage Volume36,681 shsMarket Capitalization$56.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Read More… Nutriband Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks5th Percentile Overall ScoreNTRB MarketRank™: Nutriband scored higher than 5% of companies evaluated by MarketBeat, and ranked 934th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Nutriband. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Nutriband is -7.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nutriband is -7.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNutriband has a P/B Ratio of 5.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.45% of the float of Nutriband has been sold short.Short Interest Ratio / Days to CoverNutriband has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutriband has recently increased by 83.06%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNutriband does not currently pay a dividend.Dividend GrowthNutriband does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.45% of the float of Nutriband has been sold short.Short Interest Ratio / Days to CoverNutriband has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutriband has recently increased by 83.06%, indicating that investor sentiment is decreasing significantly. News and Social Media1.0 / 5News Sentiment-0.29 News SentimentNutriband has a news sentiment score of -0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Nutriband this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nutriband insiders have not sold or bought any company stock.Percentage Held by Insiders54.09% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.70% of the stock of Nutriband is held by institutions.Read more about Nutriband's insider trading history. Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Email Address NTRB Stock News HeadlinesNutriband Issues Letter to ShareholdersDecember 31, 2024 | globenewswire.comNutriband Inc. Extends Chinese Patent to Macao for AVERSA™ Abuse Deterrent Transdermal TechnologyDecember 31, 2024 | americanbankingnews.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.January 5, 2025 | Crypto Swap Profits (Ad)Nutriband Extends Chinese Patent to Macao for its AVERSA(TM) Abuse Deterrent Transdermal TechnologyDecember 29, 2024 | stockhouse.comNutriband Secures Patent for AVERSA™ Abuse-Deterrent Technology in 46 Countries, Plans FDA Filing for Fentanyl Patch in 2025December 29, 2024 | nasdaq.comNutriband extends Chinese patent to Macao for AVERSA technologyDecember 28, 2024 | finance.yahoo.comNutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal TechnologyDecember 27, 2024 | globenewswire.comNutriband (NASDAQ:NTRB) Shares Up 1.5% - What's Next?December 27, 2024 | americanbankingnews.comSee More Headlines NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed this year? Nutriband's stock was trading at $4.71 at the beginning of the year. Since then, NTRB shares have increased by 7.6% and is now trading at $5.07. View the best growth stocks for 2025 here. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) issued its quarterly earnings results on Monday, December, 13th. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.11. The company had revenue of $0.28 million for the quarter, compared to analysts' expectations of $0.50 million. Nutriband had a negative net margin of 338.51% and a negative trailing twelve-month return on equity of 54.49%. When did Nutriband's stock split? Shares of Nutriband split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were distributed to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Nutriband own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nutriband investors own include Jiuzi (JZXN), AMC Entertainment (AMC), Aridis Pharmaceuticals (ARDS), Avenue Therapeutics (ATXI), Esports Entertainment Group (GMBL), Moleculin Biotech (MBRX) and ARMOUR Residential REIT (ARR). Company Calendar Last Earnings12/13/2021Today1/05/2025Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:NTRB CUSIPN/A CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.71) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,490,000.00 Net Margins-338.51% Pretax Margin-338.46% Return on Equity-54.49% Return on Assets-48.52% Debt Debt-to-Equity Ratio0.01 Current Ratio4.96 Quick Ratio4.83 Sales & Book Value Annual Sales$2.02 million Price / Sales27.85 Cash FlowN/A Price / Cash FlowN/A Book Value$1.01 per share Price / Book5.02Miscellaneous Outstanding Shares11,106,000Free Float6,314,000Market Cap$56.31 million OptionableNot Optionable Beta0.99 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NASDAQ:NTRB) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAmazon coin set to soar 25X – starting January 20thThis tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.